Background Breathlessness is one of the most common symptoms experienced in the
advanced stages of malignant and non‐malignant disease. Benzodiazepines are widely …

Funding for the development of this Practice Guidance was provided by the American
Association for the Study of Liver Diseases. MV was supported by aAQ19 Patient-Centered …

Patient-defined factors that are important at the end of life include being physically
independent for as long as possible, good symptom control, and spending quality time with …

PURPOSE To provide guidance on the clinical management of dyspnea in adult patients
with advanced cancer. METHODS ASCO convened an Expert Panel to review the evidence …

Breathlessness that persists despite treatment for the underlying conditions is debilitating.
Identifying this discrete entity as a clinical syndrome should raise awareness amongst …

CONTEXT: Randomized controlled trials can answer questions of efficacy, but long-term
pharmacovigilance studies generate complementary safety data. OBJECTIVES: Level I …

Background: Calls for improvement in end-of-life care have focused attention on the
management of pain and other troubling symptoms at the end of life. Objective: To describe …

Background Breathlessness is the most common and intrusive symptom of advanced non-
malignant respiratory and cardiac conditions. The Breathlessness Intervention Service (BIS) …

OBJECTIVE: In preparation for development of a palliative care intervention for patients with
heart failure (HF) and their caregivers, we aimed to characterize the HF population receiving …

Introduction Morphine may decrease the intensity of chronic breathlessness but data from a
large randomised controlled trial (RCT) are lacking. This first, large, parallel-group trial …